Verified Nov 2026
Batteries & E-Mobility
·

Buffalo, New York
·
Since 2003
Athenex is a biopharmaceutical company headquartered in Buffalo, New York, founded in 2003 and employing 50 to 100 people. It develops cancer therapies across three platforms: an oncology innovation unit for next-generation treatments, a commercial manufacturing and distribution operation, and a global supply chain division. The company serves the automotive, electric-vehicle, and medical industries through oral chemotherapy enhancements, topical treatments, and advanced cell therapies.
Athenex at a glance
Revenue
$100-250M
Est. band
Employees
50-100
Founded
2003
Headquarters
Buffalo, New York
Industries
Automotive
Electric Vehicles
Medical
Overview
Athenex is a biopharmaceutical company headquartered in Buffalo, New York, founded in 2003 and employing 50 to 100 people. It develops cancer therapies across three platforms: an oncology innovation unit for next-generation treatments, a commercial manufacturing and distribution operation, and a global supply chain division. The company serves the automotive, electric-vehicle, and medical industries through oral chemotherapy enhancements, topical treatments, and advanced cell therapies.
At a glance
Attribute | Detail |
|---|---|
Founded | 2003 |
Headquarters | Buffalo, New York |
Employees | 50-100 |
Revenue | $100-250M (estimated) |
Primary capability | Batteries & E-Mobility |
What Athenex makes
The company operates manufacturing and distribution capabilities across North America, China, and Asia, with a facility in Dunkirk, New York.
Latest developments
2025-08-14 — ST香雪:公司子公司赞助Athenex在美国开展TAEST16001产品的IND申报工作,已获得美国FDA的批准,后因其破产相关事项已终止,公司子公司已收回相关临床研发费用_股票频道_证券之星 (stockstar.com)
2025-03-06 — Athenex Investor Loses Suit Over FDA Prospects (Correct) (bloomberglaw.com)
Facilities
Athenex is headquartered in Buffalo, New York. Public sources also reference these locations:
Dunkirk, New York — pikecs.com
Company details
Athenex is a privately held firm with estimated annual revenue between $100 million and $250 million, collaborating with pharmaceutical companies, universities, and healthcare providers on oncology product development. Athenex was founded in 2003, has an estimated 50-100 employees, and is headquartered in Buffalo, New York.
Frequently asked questions
What does Athenex make?
Athenex is a biopharmaceutical company headquartered in Buffalo, New York, founded in 2003 and employing 50 to 100 people. It develops cancer therapies across three platforms: an oncology innovation unit for next-generation treatments, a commercial manufacturing and distribution operation, and a global supply chain division. The company serves the automotive, electric-vehicle, and medical industries through oral chemotherapy enhancements, topical treatments, and advanced cell therapies.
Where is Athenex headquartered?
Athenex is headquartered in Buffalo, New York (1001 Main Street, Buffalo, New York, 14203).
When was Athenex founded?
Athenex was founded in 2003.
How big is Athenex?
Athenex has an estimated 50-100 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
